BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8535199)

  • 21. [An intensive chemotherapy of adult T-cell leukemia/lymphoma].
    Taguchi H
    Rinsho Ketsueki; 1996 Aug; 37(8):654-60. PubMed ID: 8827873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human T-cell leukemia virus type I Tax genotype analysis in Okinawa, the southernmost and remotest islands of Japan: Different distributions compared with mainland Japan and the potential value for the prognosis of aggressive adult T-cell leukemia/lymphoma.
    Sakihama S; Saito M; Kuba-Miyara M; Tomoyose T; Taira N; Miyagi T; Hayashi M; Kinjo S; Nakachi S; Tedokon I; Nishi Y; Tamaki K; Morichika K; Uchihara JN; Morishima S; Karube KN; Tanaka Y; Masuzaki H; Fukushima T
    Leuk Res; 2017 Oct; 61():18-24. PubMed ID: 28866351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term study of indolent adult T-cell leukemia-lymphoma.
    Takasaki Y; Iwanaga M; Imaizumi Y; Tawara M; Joh T; Kohno T; Yamada Y; Kamihira S; Ikeda S; Miyazaki Y; Tomonaga M; Tsukasaki K
    Blood; 2010 Jun; 115(22):4337-43. PubMed ID: 20348391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Higher average chemotherapy dose intensity improves prognosis in patients with aggressive adult T-cell leukemia/lymphoma.
    Sekine M; Kameda T; Shide K; Maeda K; Toyama T; Kawano N; Takeuchi M; Kawano H; Sato S; Ishizaki J; Kukita T; Kamiunten A; Akizuki K; Tahira Y; Shimoda H; Hidaka T; Yamashita K; Matsuoka H; Kitanaka A; Kubuki Y; Shimoda K
    Eur J Haematol; 2021 Mar; 106(3):398-407. PubMed ID: 33301622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult T-cell leukemia/lymphoma in Taiwan: an analysis of 17 patients and review of the literature.
    Lee CW; Chang MC; Chang YF; Hsieh RK; Lin J; Chen KS
    Asia Pac J Clin Oncol; 2010 Sep; 6(3):161-4. PubMed ID: 20887496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Multicenter Retrospective Study of Mogamulizumab Efficacy in Adult T-Cell Leukemia/Lymphoma.
    Iyama S; Sato T; Ohnishi H; Kanisawa Y; Ohta S; Kondo T; Mori A; Tsutsumi Y; Kuroda H; Kakinoki Y; Yamamoto S; Takahashi T; Shindo M; Torimoto Y; Sato K; Iwasaki H; Haseyama Y; Kohda K; Nagamachi Y; Hirayama Y; Sakai H; Hirata Y; Fukuhara T; Ikeda H; Kobune M; Kato J; Kurosawa M
    Clin Lymphoma Myeloma Leuk; 2017 Jan; 17(1):23-30.e2. PubMed ID: 27727135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine.
    Gill PS; Harrington W; Kaplan MH; Ribeiro RC; Bennett JM; Liebman HA; Bernstein-Singer M; Espina BM; Cabral L; Allen S
    N Engl J Med; 1995 Jun; 332(26):1744-8. PubMed ID: 7760890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study.
    Ishida T; Jo T; Takemoto S; Suzushima H; Uozumi K; Yamamoto K; Uike N; Saburi Y; Nosaka K; Utsunomiya A; Tobinai K; Fujiwara H; Ishitsuka K; Yoshida S; Taira N; Moriuchi Y; Imada K; Miyamoto T; Akinaga S; Tomonaga M; Ueda R
    Br J Haematol; 2015 Jun; 169(5):672-82. PubMed ID: 25733162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
    Ogura M; Ishida T; Tsukasaki K; Takahashi T; Utsunomiya A
    Cancer Chemother Pharmacol; 2016 Jul; 78(1):199-207. PubMed ID: 27289375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study.
    Suehiro Y; Hasegawa A; Iino T; Sasada A; Watanabe N; Matsuoka M; Takamori A; Tanosaki R; Utsunomiya A; Choi I; Fukuda T; Miura O; Takaishi S; Teshima T; Akashi K; Kannagi M; Uike N; Okamura J
    Br J Haematol; 2015 May; 169(3):356-67. PubMed ID: 25612920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M.
    Shimoyama M; Ota K; Kikuchi M; Yunoki K; Konda S; Takatsuki K; Ichimaru M; Ogawa M; Kimura I; Tominaga S
    J Clin Oncol; 1988 Jan; 6(1):128-41. PubMed ID: 2891797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma.
    Hodson A; Crichton S; Montoto S; Mir N; Matutes E; Cwynarski K; Kumaran T; Ardeshna KM; Pagliuca A; Taylor GP; Fields PA
    J Clin Oncol; 2011 Dec; 29(35):4696-701. PubMed ID: 22042945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Outcome of treatment protocol 8704T for childhood T cell leukemia and lymphoma].
    Horibe K; Katayama I; Miyajima Y; Matsumoto K; Fukuda M; Yoshida J; Kudo K; Kato K; Kojima S; Matsuyama T
    Rinsho Ketsueki; 1994 Jul; 35(7):657-64. PubMed ID: 8065018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A childhood chemotherapy protocol improves overall survival among adults with T-lymphoblastic lymphoma.
    Zhu MY; Wang H; Huang CY; Xia ZJ; Chen XQ; Geng QR; Wang WD; Wang L; Lu Y
    Oncotarget; 2016 Jun; 7(25):38884-38891. PubMed ID: 27150061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mogamulizumab for the treatment of relapsed or refractory adult T-cell leukemia-lymphoma.
    Winsett FT; Lewis DJ; Duvic M
    Expert Rev Hematol; 2017 Sep; 10(9):757-760. PubMed ID: 28756726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients.
    Morel P; Lepage E; Brice P; Dupriez B; D'Agay MF; Fenaux P; Gosselin B; Bauters F; Gisselbrecht C
    J Clin Oncol; 1992 Jul; 10(7):1078-85. PubMed ID: 1607914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved survival using an intensive, pediatric-based chemotherapy regimen in adults with T-cell acute lymphoblastic leukemia.
    Al-Khabori M; Minden MD; Yee KW; Gupta V; Schimmer AD; Schuh AC; Xu W; Brandwein JM
    Leuk Lymphoma; 2010 Jan; 51(1):61-5. PubMed ID: 20017600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CEOP-B alternated with VIMB in intermediate-grade and high-grade non-Hodgkin's lymphoma: a pilot study.
    De Lena M; Ditonno P; Lorusso V; Brandi M; Timurian A; Marzullo F; Ventrella V; Pellecchia A
    J Clin Oncol; 1995 Apr; 13(4):953-60. PubMed ID: 7535844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival.
    Kim MK; Kim S; Lee SS; Sym SJ; Lee DH; Jang S; Park CJ; Chi HS; Huh J; Suh C
    Ann Hematol; 2007 Jun; 86(6):435-42. PubMed ID: 17256144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol.
    Hallböök H; Gustafsson G; Smedmyr B; Söderhäll S; Heyman M; ;
    Cancer; 2006 Oct; 107(7):1551-61. PubMed ID: 16955505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.